Competitive intelligence on 
 small-molecule drugs and 
 the 90,000 global patents 
 covering them 

Start your free trial now

DrugPatentWatch Archives

You are currently viewing the 2000 archives
Click here to return to the current data set

DrugPatentWatch Ultimate Plan Preview

Profile for Tradename: ERYTHROCIN STEARATE

« Back to Dashboard

Erythrocin Stearate is a drug marketed by Arbor Pharms Llc and is included in one NDA.

The generic ingredient in ERYTHROCIN STEARATE is erythromycin stearate. There are ninety-five drug master file entries for this compound. Additional details are available on the erythromycin stearate profile page.

Summary for Tradename: ERYTHROCIN STEARATE

Patents:0
Applicants:1
NDAs:1

Clinical Trials for: ERYTHROCIN STEARATE

Glossary
Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Exclusivity Expiration
Abbott
ERYTHROCIN STEARATE
erythromycin stearate
Tablet; Oral060359Approved prior to Jan 1, 1982RXNo<disabled><disabled>
Abbott
ERYTHROCIN STEARATE
erythromycin stearate
Tablet; Oral060359Approved prior to Jan 1, 1982DISCNNo<disabled><disabled>
Abbott
ERYTHROCIN STEARATE
erythromycin stearate
Tablet; Oral060359Approved prior to Jan 1, 1982RXYes<disabled><disabled>
This preview shows a limited data set
Subscribe for full access, or try a free trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a free trial or see the plan comparison

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.

Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided information. There is no warranty that the information contained herein is error free. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Connect with Social Media:

Follow DrugPatentWatch on Twitter Connect with DrugPatentWatch on Linkedin Drug Patents on LinkedIn

Copyright © 2002-2014 thinkBiotech LLC. ISSN: 2162-2639

Other thinkBiotech sites: PatentStatBiotechBlogJournal of Commercial Biotechnology

`abc